RECOMBINANT LECTINES BINDING TO CANCER CELLS WITH ANTITUMOR ACTIVITY AND PREPARATION METHOD

摘要

The present invention discloses genes for new variants in E.coli that are more close to the wild type lectin sequence but still differ in surface charges. This recombinant version (exemplified Rec-2 and Rec-3) are cancer cell binding with anti tumor activity show blood group specificity similar to the native lectin but retains the stability and the solubility properties.